Imprimis Pharmaceuticals announced that it has launched a new program to provide ophthalmologists and optometrists with custom compounded ophthalmic medications that are increasingly difficult to find and typically needed on an urgent basis, according to a company news release. The goal of this program is to provide high-quality compounded medications from an Imprimis FDA-inspected facility and ship it within 24-48 hours. Imprimis intends to make this program available in all 50 US states.
"Recent changes in ophthalmic compounding has made it such a challenge to access critical compounded medications, especially for infectious keratitis, where urgent care is essential," Marjan Farid, MD, Director of Cornea, Cataract, and Refractive Surgery, Vice-Chair of Ophthalmic Faculty at the Gavin Herbert Eye Institute, University of California Irvine, said in a company news release. "Having a trusted partner pharmacy such as Imprimis that puts the patient first and provides timely and cost-efficient medications is so valuable to the ophthalmic community."
Imprimis CEO, Mark L. Baum stated, “The mission of our company is to make innovative medications accessible and affordable for patients. Over the past year, a growing number of our customers have made us aware of their inability to access sight saving medications that are needed on an emergent basis. As a partner to thousands of eye care professionals and in furtherance of our corporate mission, we are pleased to now make these critical medications available.”
Physicians can order custom compounded formulations on an as needed basis for their patients. To order a custom compound, please click here to download the order form.